JPRN-UMIN000033586已完成未知
A randomized placebo-controlled double-blind parallel-group trial on lipid metabolic effect of a food ingredient (G-PX) - An RCT (randomized controlled trial) on lipid metabolic effect of a food ingredient (G-PX)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Persons who are receiving any treatment at the time of participation in the trial (2)Pregnant women (including those who are potentially pregnant) or lactating women (3)Smokers (4)Persons who made a blood component donation or whole blood donation of 200 mL within 4 weeks prior to the trial food intake (5)Persons who made a whole blood donation of 400 mL within 16 weeks prior to the trial food intake (6)Persons who underwent blood drawing of over 1000 mL within 48 weeks prior to the trial food intake (7)Persons who are participating in other trials or studies (8)Persons who meet any of the following: 1)Persons with heart, liver or kidney diseases (including complications of other diseases) 2)Persons with medical history of circulatory diseases 3)Persons with diabetes mellitus 4)Persons currently receiving treatment for or with medical history of serious diseases such as cancer or asthma (9)Persons with history of major surgery in the site of gastrointestinal tract such as gastrectomy, gastroenterostomy, or intestinal resection
研究者
相似试验
进行中（未招募）
不适用
A randomized double-blind placebo-controlled parallel group study of SHR -5 extract of Rhodiola Rosea as adjuvant therapy in patients with stress related fatigue.EUCTR2004-002642-35-SEGreen Medicine AB60
进行中（未招募）
3 期
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)Allergic fungal rhinosinusitisJPRN-jRCT2041210031Tanaka Tomoyuki62
进行中（未招募）
3 期
Study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS)CTRI/2022/05/042593Sanofi Healthcare India Private Limited
进行中（未招募）
不适用
A Double Blind Randomized Placebo-Controlled Parallel Group Dose-Ranging Study of Oral COL-144 in the Acute Treatment of MigraineMedDRA version: 9.1Level: PTClassification code 10027599Term: MigraineMigraineEUCTR2008-005010-43-BECoLucid Pharmaceuticals, Inc.450
进行中（未招募）
不适用
A Double Blind Randomized Placebo-Controlled Parallel Group Dose-Ranging Study of Oral COL-144 in the Acute Treatment of MigraineMedDRA version: 9.1Level: PTClassification code 10027599Term: MigraineMigraineEUCTR2008-005010-43-DECoLucid Pharmaceuticals, Inc.450